Latest healthcare news
Are Those Aged Over 100 Less Susceptible to the Features of Aging?
An interesting article published in Nature by Rimal and Patterson looks at this issue. As we age, we are more likely to develop aging related illnesses such as cardiovascular disease, cancer and type 2 diabetes. Yet centenarians, those who are over the age...
Can Neutralising Antibody Titres be a Predictor of Protection Against the SARS-CoV-2 Variants and What is the Impact of Boosting?
An interesting article published by Cromer and others in The Lancet, November 15 discusses this issue. Several SARS-CoV-2 variants of concern have been identified which partly escape serum neutralisation elicited by the current...
The Shingrix Vaccine and COVID-19
The Shingrix vaccine, shingles vaccine appears to give benefit and help to reduce the risk of COVID-19 in older adults. An interesting preprint published in medRxiv by Bruxvoort and others suggests that vaccines may elicit long term boosting of innate immune responses...
COVID-19 Infection, Immunity from Vaccination or Infection?
A personal view published by Milne and others in The Lancet Respiratory Medicine October 21st 2021, looks at this. It is further discussed by Altmann and others in a comment published October 21st 2021. Many nations are pursuing the rollout of SARS-CoV-2...
Can Patients Who Have Antiphospholipid Antibodies Have the mRNA COVID-19 Vaccine?
An interesting correspondence in The Lancet rheumatology published by Sciascia October 20th 2021 discusses this issue. Vaccines represent a cornerstone in controlling the COVID-19 pandemic. The availability of data on the immunogenicity and...
The Toxic Effects from Ivermectin Use Associated with the Prevention and treatment of COVID-19
An interesting letter published in the New England Journal of Medicine by Courtney Temple and others October 20th 2021 highlights this issue. Ivermectin is approved by the FDA as an oral treatment for intestinal strongyloidiasis and onchocerciasis and is a...
A New but Old Treatment for Lyme’s Disease
A study published by Leimer and others in Cell October 6th 2021, highlighted the rediscovery of the antibiotic hygromycin A against Lyme’s disease. Lyme’s disease is on the rise. It is caused by the spirochete Borreliella burgdorferi and affects an...
COVID-19 Therapies in the Community Setting
The editorial published in Lancet Infectious Diseases October 14th 2021, reviews this issue. There has been widespread coverage in the media of Merck and Ridgeback's interim results of their phase 2 trial of the antiviral molnupiravir. According to a press...
Tau Protein and Neurodegenerative Diseases
An article published by Stahlberg and Riek in Nature September 2021 establishes that high resolution structures of previously uncharacterised strains of tau fibril purified from the postmortem brains of individuals with various neurodegenerative diseases could be used...
What Side Effects are Possible Following SARS-Cov-2 Vaccination Booster?
A paper from America published by the CDC shows that people who have received a vaccine booster are reporting side effects which are similar to those after the second dose. The report relies on more than 12,500 submissions via V-safe, the CDC smartphone based...